Press Releases

Anshul Thakral Appointed to the TriNetX Board of Directors

Cambridge, MA, May 5, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the appointment of Anshul Thakral to the company’s board of directors. Mr. Thakral...

Blood Cancer Journal Study Finds Multiple Myeloma Patients at Higher Risk of COVID-19 Infection and Mortality

TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Universitario 12 de Octubre to leverage European real-world data for a study that found that multiple myeloma (MM) patients were more likely to contract the COVID-19 virus and suffer a higher risk of mortality than non-MM patients.

Mitsui Signs Partnership Agreement with TriNetX to Expand its Global Research Network in Japan

Mitsui & Co., Ltd. (“Mitsui”, Head Office: Tokyo, President and CEO: Kenichi Hori) and TriNetX, LLC (“TriNetX”, Head Office: Massachusetts, U.S., CEO: Gadi Lachman), the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, have signed a partnership agreement to support the expansion of TriNetX’s network in Japan.

TriNetX Announces the Appointment of Shogo Wakabayashi as Japan Country Manager

Cambridge, MA, January 27, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Shogo Wakabayashi has joined the company as Country Manager for Japan. Wakabayashi, a business leader with extensive global experience bringing new offerings to market, will be focused on expanding the TriNetX network among healthcare organizations in Japan.